Contemplating Pliva V. Mensing

Law360, New York (July 15, 2011, 2:13 PM EDT) -- Federal laws governing the labeling of generic drugs preempt state law failure-to-warn claims against generic drug manufacturers, according to the U.S. Supreme Court’s 5-4 opinion in Pliva Inc. v. Mensing, No. 09-993 on June 23, 2011.

Justice Clarence Thomas, writing for the majority, held that federal law requires generic labeling to be the same as the U.S. Food and Drug Administration-approved labeling of the corresponding brand-name drug, making it impossible for generic manufacturers to simultaneously comply with federal labeling requirements and state laws requiring a generic...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.